Dr. Tyler Curiel is an internationally-recognized expert in innovative treatment of cancer using the body’s own immune system. His training includes a bachelor’s degree from the University of Georgia, a master of public health at Harvard University and his M.D. at Duke University. Dr. Curiel did his residency in internal medicine at Yale University, an infectious disease fellowship at Harvard University and a fellowship in medical oncology at the University of Colorado. He has been the national chair of the American Society of Clinical Oncology Group on experimental therapeutics. He has published extensively on the immune system and cancer, and has been awarded many prestigious grants from the National Institutes of Health for his work.